Glenmark Pharma cuts price of COVID-19 drug by 27 pc to Rs 75/tablet
Glenmark Pharmaceuticals had launched FabiFlu last month at a price of Rs 103 per tablet
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Favipiravir
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against…
In collaboration with Laxai Life Sciences, it aims to determine the safety and efficacy of three combination drugs…
Dr Reddy’s signs agreement with FUJIFILM and Global Response Aid for Avigan (favipiravir)
Dr Reddy’s would have exclusive rights for development, selling and distribution of Avigan in India.
Why drug repurposing needs first good science, then hope
The COVID-19 adversity has proved to be an opportunity to galvanise drug repurposing and development in India. But it is important…
Maha govt plans to procure 10000 vials of remdesivir from Cipla
It also plans to procure favipiravir from Glenmark
Glenmark set to get manufacturing and marketing approval for favipiravir
Sources inform that SEC has recommended the grant of permission, along with some recommendations, the company plans to launch its…
Optimus launches COVID-19 drug Favipiravir, commences commercial export
The drug is being marketed under the brand name Favicovid both in India and other countries
ICT, Lasa succeed in Favipiravir drug synthesis, to commence production
The collaborators aim to manufacture close to 10,000 doses of the antiviral to begin with
Local API production in India for COVID-19 repurposed drugs may offer competitive advantage:…
The advantages will be in terms of supply and price for the formulations manufactured in India, be it remdesivir, favipiravir or…
Indian pharma companies looking to leverage opportunities in drug repurposing: GlobalData
In race for favipiravir clinical trials for COVID-19